BlackRock »

Bolt Biotherapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Bolt Biotherapeutics (BOLT) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Bolt Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bolt Biotherapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bolt Biotherapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $175k 270k 0.65

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Bolt Biotherapeutics

Tang Capital Management
Sofinnova Ventures
Pivotal bioVenture Partners Investment Advisor
Nan Fung Group Holdings
Vanguard Group
Samsara BioCapital
Board of Trustees of The Leland Stanford Junior University
Newtyn Management
Geode Capital Management
Renaissance Technologies
BlackRock
BlackRock
Susquehanna International
Bridgeway Capital Management
Two Sigma Securities

View all funds holding Bolt Biotherapeutics